93 related articles for article (PubMed ID: 28138723)
1. [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].
Keller M; Arora R; Schmiedle G; Kastenberger T
Orthopade; 2017 Apr; 46(4):321-327. PubMed ID: 28138723
[TBL] [Abstract][Full Text] [Related]
2. The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
Murphy LE; Murphy KM; Kilpatrick SM; Thompson NW
Ulster Med J; 2017 May; 86(2):94-98. PubMed ID: 29535479
[TBL] [Abstract][Full Text] [Related]
3. Collagenase clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.
Warwick D; Arner M; Pajardi G; Reichert B; Szabo Z; Masmejean EH; Fores J; Chapman DS; Gerber RA; Huard F; Seghouani A; Szczypa PP;
J Hand Surg Eur Vol; 2015 Feb; 40(2):124-32. PubMed ID: 24470559
[TBL] [Abstract][Full Text] [Related]
4. Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days.
Schulze SM; Tursi JP
Hand (N Y); 2014 Dec; 9(4):447-58. PubMed ID: 25414604
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture.
Bainbridge C; Gerber RA; Szczypa PP; Smith T; Kushner H; Cohen B; Hellio Le Graverand-Gastineau MP
J Plast Surg Hand Surg; 2012 Sep; 46(3-4):177-83. PubMed ID: 22670890
[TBL] [Abstract][Full Text] [Related]
6. Long-term recurrence of Dupuytren's disease treated with clostridium histolitycum collagenase. Surgical treatment and anatomopathological study.
Simón-Pérez C; Rodríguez-Mateos JI; Maestro IA; Alvarez-Quiñones M; Simon-Perez E; Martín-Ferrero MA
Arch Orthop Trauma Surg; 2024 May; 144(5):2085-2091. PubMed ID: 38653835
[TBL] [Abstract][Full Text] [Related]
7. Collagenase Clostridium histolyticum: emerging practice patterns and treatment advances.
Warwick D; Arandes-Renú JM; Pajardi G; Witthaut J; Hurst LC
J Plast Surg Hand Surg; 2016 Oct; 50(5):251-61. PubMed ID: 27050718
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.
Syed F; Thomas AN; Singh S; Kolluru V; Emeigh Hart SG; Bayat A
PLoS One; 2012; 7(2):e31430. PubMed ID: 22384021
[TBL] [Abstract][Full Text] [Related]
9. Industry Sponsorship Bias in Collagenase Clinical Trials for Dupuytren Disease: A Meta-analysis.
Gray KM; Khatiwada P; Capito AE
Ann Plast Surg; 2024 Apr; 92(4):389-394. PubMed ID: 38527344
[TBL] [Abstract][Full Text] [Related]
10. Dupuytren's Disease: A Novel Minimally Invasive Pull-Through Technique.
Maruccia M; Tedeschi P; Sisto F; Converti I; Giudice G; Elia R
Arch Plast Surg; 2024 May; 51(3):295-303. PubMed ID: 38737838
[No Abstract] [Full Text] [Related]
11. Long-term assessment of collagenase treatment for Dupuytren's contracture: A 10-year follow-up study.
Passiatore M; Cilli V; Cannella A; Caruso L; Sassara GM; Taccardo G; De Vitis R
World J Orthop; 2024 Apr; 15(4):355-362. PubMed ID: 38680672
[TBL] [Abstract][Full Text] [Related]
12. Collagenase Clostridium Histolyticum for the Treatment of Dupuytren Disease: A Delphi-Based Consensus Study.
Pess GM; Hurley D; Verheyden JR; Benhaim P
J Hand Surg Glob Online; 2024 Mar; 6(2):151-158. PubMed ID: 38903838
[TBL] [Abstract][Full Text] [Related]
13. Vascular Complication after Collagenase Injection and Manipulation for Dupuytren's Contracture: A Case Report.
Kawano Y; Hagiwara T; Tanaka N; Nakamura T; Takeda H; Itabashi T; Furukawa M; Kikuchi K; Okuyama K
JMA J; 2019 Sep; 2(2):196-199. PubMed ID: 33615032
[TBL] [Abstract][Full Text] [Related]
14. Collagenase Treatment for Dupuytren Contracture of the Metacarpophalangeal Joint After Arthrodesis of the Proximal Interphalangeal Joint.
Stevens CS; Pavano C; Rodner CM
J Hand Surg Glob Online; 2023 Nov; 5(6):843-844. PubMed ID: 38106945
[TBL] [Abstract][Full Text] [Related]
15. Delayed vascular complication after collagenase injection for Dupuytren disease.
Nordenskjöld J; Nilsson J; Kalaf R; Atroshi I
BMC Musculoskelet Disord; 2023 Oct; 24(1):837. PubMed ID: 37872560
[TBL] [Abstract][Full Text] [Related]
16. Phalangeal Fracture During Attempted Dupuytrens Release Following Clostridial Collagenase Injection: Case Report.
Lewallen LW; Rizzo M
J Orthop Case Rep; 2017; 7(4):21-24. PubMed ID: 29181346
[TBL] [Abstract][Full Text] [Related]
17. The Rationale for Treating the Nodule in Dupuytren's Disease.
Ketchum LD
Plast Reconstr Surg Glob Open; 2014 Dec; 2(12):e278. PubMed ID: 25587512
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
[TBL] [Abstract][Full Text] [Related]
19. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Nayar SK; Pfisterer D; Ingari JV
Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
[TBL] [Abstract][Full Text] [Related]
20. Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren's disease in 788 patients: the Austrian register.
Rohit A; Peter A; Paul A; Anja B; Christian D; Renate D; Stefan G; Dietmar H; Johannes J; Peter K; Marco K; Martin L; Maximilian N; Christoph P; Gernot S; Gerald S; Tobias S; Matthias W; Armin Z; Markus G
Arch Orthop Trauma Surg; 2019 Sep; 139(9):1315-1321. PubMed ID: 31317303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
